George A Baumbach is a notable inventor based in Knightdale, NC (US). He holds a total of 7 patents, showcasing his significant contributions to the field of medical technology. His work primarily focuses on innovative methods and devices that enhance medical procedures.

Latest Patents

Among his latest patents is a method and device for delivering fibrin glue. This invention involves activating and applying a solution of fibrinogen to form fibrin glue at a desired site. The method includes contacting the solution of fibrinogen with immobilized thrombin under specific conditions that result in a solution of polymerizable fibrin. The device is designed with a housing that contains a compartment for the fibrinogen solution, a container for immobilized thrombin, and a structure that facilitates the contact between the two components. This allows for the effective delivery of the activated solution to the desired site.

Another significant patent is related to alpha-1 proteinase inhibitor binding peptides. These peptides are designed to bind to alpha-1 Proteinase inhibitor (AlPI) and feature an available AlPI binding domain. The patent outlines various preferred sequences for these peptides and describes a method for using them in an affinity chromatography process to purify AlPI.

Career Highlights

George A Baumbach is currently associated with Bayer Corporation, where he continues to innovate and develop new technologies. His work has had a profound impact on medical practices, particularly in the area of surgical procedures and treatments.

Collaborations

He has collaborated with notable coworkers, including Christopher A Dadd and David J Hammond, contributing to a dynamic and innovative work environment.

Conclusion

George A Baumbach's contributions to the field of medical technology through his patents and collaborations highlight his role as a significant inventor. His innovative methods and devices continue to advance medical practices and improve patient outcomes.